Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Bioexx Specialty Proteins (BXI.TO)

Add to Watchlists
Create an Alert
0.01 +0.00  +0.00% TSX Apr 23, 8:00PM Delayed by 15 min Currency in CAD
View Full Chart
BXI.TO Price Chart
View All Performance Charts

BXI.TO Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Bioexx Specialty Proteins is down 87.50% over the last year vs and S&P 500 Total Return up 22.59%.

Get Quote for
Advertisement

Portfolio Strategies Featuring BXI.TO

Did Bioexx Specialty Proteins make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

BXI.TO Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: Canada
  • Headquarters State/Province: Ontario
  • Incorporation Country: Canada
  • Incorporation State/Province: N/A
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A

Bioexx Specialty Proteins, Inc. is involved in the development and commercialization of processing technologies, for use in the extracting various active ingredients from organic and inorganic materials.

Recent Quotes

Symbol Price Chg Chg % Market Cap
BXI.TO 0.01 +0.00 +0.00% 2.159M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.